These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29491833)

  • 21. Reduced Levels of Cerebrospinal Fluid/Plasma Aβ40 as an Early Biomarker for Cerebral Amyloid Angiopathy in RTg-DI Rats.
    Zhu X; Xu F; Hoos MD; Lee H; Benveniste H; Nostrand WEV
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasoactive Intestinal Peptide Decreases β-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer's Disease.
    Korkmaz OT; Ay H; Aytan N; Carreras I; Kowall NW; Dedeoglu A; Tuncel N
    J Mol Neurosci; 2019 Jul; 68(3):389-396. PubMed ID: 30498985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural basis of C-terminal β-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer's disease.
    La Porte SL; Bollini SS; Lanz TA; Abdiche YN; Rusnak AS; Ho WH; Kobayashi D; Harrabi O; Pappas D; Mina EW; Milici AJ; Kawabe TT; Bales K; Lin JC; Pons J
    J Mol Biol; 2012 Aug; 421(4-5):525-36. PubMed ID: 22197375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strengths and Weaknesses of the Gray Mouse Lemur (
    Pifferi F; Epelbaum J; Aujard F
    Front Pharmacol; 2019; 10():1291. PubMed ID: 31736761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative analysis of tau protein-immunoreactive accumulations and beta amyloid protein deposits in the cerebral cortex of the mouse lemur, Microcebus murinus.
    Giannakopoulos P; Silhol S; Jallageas V; Mallet J; Bons N; Bouras C; Delaère P
    Acta Neuropathol; 1997 Aug; 94(2):131-9. PubMed ID: 9255387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
    Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
    J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
    Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
    Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain.
    Petanceska SS; Nagy V; Frail D; Gandy S
    Neurology; 2000 Jun; 54(12):2212-7. PubMed ID: 10881241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical analysis of cerebral cortical and vascular lesions in the primate Microcebus murinus reveal distinct amyloid beta1-42 and beta1-40 immunoreactivity profiles.
    Mestre-Francés N; Keller E; Calenda A; Barelli H; Checler F; Bons N
    Neurobiol Dis; 2000 Feb; 7(1):1-8. PubMed ID: 10671318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI).
    de Rojas I; Romero J; Rodríguez-Gomez O; Pesini P; Sanabria A; Pérez-Cordon A; Abdelnour C; Hernández I; Rosende-Roca M; Mauleón A; Vargas L; Alegret M; Espinosa A; Ortega G; Gil S; Guitart M; Gailhajanet A; Santos-Santos MA; Moreno-Grau S; Sotolongo-Grau O; Ruiz S; Montrreal L; Martín E; Pelejà E; Lomeña F; Campos F; Vivas A; Gómez-Chiari M; Tejero MA; Giménez J; Pérez-Grijalba V; Marquié GM; Monté-Rubio G; Valero S; Orellana A; Tárraga L; Sarasa M; Ruiz A; Boada M;
    Alzheimers Res Ther; 2018 Nov; 10(1):119. PubMed ID: 30497535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations Between β-Amyloid Kinetics and the β-Amyloid Diurnal Pattern in the Central Nervous System.
    Lucey BP; Mawuenyega KG; Patterson BW; Elbert DL; Ovod V; Kasten T; Morris JC; Bateman RJ
    JAMA Neurol; 2017 Feb; 74(2):207-215. PubMed ID: 27992627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.
    Gurol ME; Irizarry MC; Smith EE; Raju S; Diaz-Arrastia R; Bottiglieri T; Rosand J; Growdon JH; Greenberg SM
    Neurology; 2006 Jan; 66(1):23-9. PubMed ID: 16401840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin.
    Parthasarathy R; Chow KM; Derafshi Z; Fautsch MP; Hetling JR; Rodgers DW; Hersh LB; Pepperberg DR
    Exp Eye Res; 2015 Sep; 138():134-44. PubMed ID: 26142956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The art of growing old: environmental manipulation, physiological rhythms, and the advent of Microcebus murinus as a primate model of aging.
    Gerber L
    Hist Philos Life Sci; 2020 Jun; 42(2):26. PubMed ID: 32529381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 mice.
    de Retana SF; Marazuela P; Solé M; Colell G; Bonaterra A; Sánchez-Quesada JL; Montaner J; Maspoch D; Cano-Sarabia M; Hernández-Guillamon M
    Alzheimers Res Ther; 2019 May; 11(1):42. PubMed ID: 31077261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations Between Hepatic Functions and Plasma Amyloid-Beta Levels-Implications for the Capacity of Liver in Peripheral Amyloid-Beta Clearance.
    Wang YR; Wang QH; Zhang T; Liu YH; Yao XQ; Zeng F; Li J; Zhou FY; Wang L; Yan JC; Zhou HD; Wang YJ
    Mol Neurobiol; 2017 Apr; 54(3):2338-2344. PubMed ID: 26957302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of Aβ42 in the Brain and Bodily Fluids of Rhesus Monkeys with Aging.
    Zhao Q; Lu J; Yao Z; Wang S; Zhu L; Wang J; Chen B
    J Mol Neurosci; 2017 Jan; 61(1):79-87. PubMed ID: 27647310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.